RHA® Collection

Designed for Dynamics

RHA® Collection

Designed for Dynamics

RHA® is Resilient Hyaluronic Acid, and represents the latest advancement in HA filler science: designed for dynamic wrinkles and folds to help you keep your patients looking beautiful at rest, and flawless in motion.

Indications and Important Safety Information

The RHA® collection of resilient hyaluronic acid (HA) fillers includes RHA® 2, RHA® 3 and RHA® 4. RHA® 2 and RHA® 3 are indicated for injection into the mid-to-deep dermis for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds; and RHA® 4 is indicated for injection in the deep dermis to superficial subcutaneous tissue for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds; in adults 22 or older.READ MORE

RHA® is the first and only resilient hyaluronic acid filler designed for facial dynamics.

person

Introducing The 4th Dimension of Facial Aesthetics: Dynamics

The RHA® collection is designed to adapt to the dynamic demands of the face, for a look that’s beautiful at rest and flawless in motion.

splash

Innovative Preserved Network Technology

The RHA® Collection is formulated to be more like natural HA found in the skin.

Preserved Network Technology preserves HA chain length and intrinsic non-covalent bonds to more closely resemble natural HA.

person

No Compromise

The RHA® Collection offers both
duration and long-term safety

  • Proven clinical effectiveness and duration up to 15 months*†

  • No delayed-onset treatment-related adverse events observed in the US clinical studies*

*Clinical effectiveness and safety were demonstrated in 2 pivotal studies, each a 15-month, randomized, double-blinded, within-subject, multicenter, noninferiority, prospective trial. Study 1 (174 subjects): 74 RHA® 2/control treatment group, 74 RHA® 3/control treatment group, and 26 no-treatment group. Study 2 (140 subjects): 120 RHA® 4/control treatment group and 20 no-treatment group.

Duration based on blinded evaluator assessments at Month 15 in the 2 pivotal studies, the percentages of responders ( ≥ 1 grade improvement on the wrinkle severity rating scale) were 80.9% for RHA 2, 78.7% for RHA 3, and 89.2% for RHA 4.

RHA® is the Latest Innovation in HA Technology

  • Early dermal filler products based on bovine and human collagen

  • Restylane® NASHA™ technology approved in the EU to address deep wrinkles

  • Juvéderm® Hylacross™ technology is approved in the EU for addressing wrinkles and folds

  • Juvéderm® Vycross™ technology approved in the EU for volumizing

  • Emervel® with OBT™ technology approved in the EU (later launched in the US as Refyne® and Defyne® for static expression).

  • RHA® changes the game in Europe with gel designed for dynamic wrinkles and natural expressions

  • RHA® available in the US for dynamic wrinkles and folds - the 4th dimension